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Clostridium difficile is an anaerobic Gram-positive pathogen with high treatment costs and 
mortality and very high antibiotic tolerance. Antimicrobial host-defense peptides (HDPs) 
produced naturally by animal immune systems are promising candidates to develop novel therapies 
for bacterial infection because they cause oxidative stress that damages multiple targets in bacterial 
cells, so it is difficult for bacteria to evolve resistance to these attacks.  
Piscidins, fish-derived HDPs that can also form complexes with copper (Cu) to enhance 
their activities, are very active against multiple bacterial species in an aerobic environment. We 
examined their activity against C. difficile and other species in an anaerobic environment and found 
that the interaction of piscidins and copper is different in different oxygen environments. Piscidins 
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Combating harmful bacterial infection is a complex process that requires a sophisticated 
and diligent approach, especially when it involves Clostridium difficile bacteria (Figure 1). 
Clostridium difficile is a Gram-positive anaerobic spore producing bacterium, found in the 
intestine of many animals and humans. Imbalance to the commensal microbiota due to antibiotic 
treatment, is the major risk factor in Clostridium difficile infection (CDI) after exposure to C. 
difficile spores (1). The longitudinal section of C. difficile bacterium is shown in Figure 1 
               
 
Figure 1: The longitudinal section of Clostridium difficile bacterium. Shown are the vegetative cell, the 
peptidoglycan capsule which absorbs Gram stain, and daughter which has differentiated into spore. 
Image adapted from Jane Hartman (trilobiteglasswork) Etsy.com 




The Clostridium difficile life cycle has two main stages. Metabolically dormant C. difficile 
spores persist in the environment and germinate if and only if they are ingested by a susceptible 
host (36). Clostridium difficile infection (CDI) is a consequence of exposure to C. difficile spores 
which germinate in the digestive tract to form the vegetative cells. Vegetative cells are the 
replicative form that produced the toxin, causes disease symptoms and can germinate into new 
spores to spread the infection into new host (33). C. difficile toxins disrupt host cell-cell junctions 
in the epithelium, which results in CDI symptoms, including fever, diarrhea, stomach pain, nausea, 
enlargement of colon and death in humans (2). CDI is associated with more than 20% of hospital-
acquired diarrhea cases in United State (3). It costs more than $5billion yearly to treat and up to 
45,000 lives are lost annually in United States alone (3).  
CDI is resistant to multiple classes of antibiotics and has a 15 – 26% recurrence rate after 
treatment (4-6). When humans are exposed to pathogens the first line of defense is the innate 
immune system, which releases reactive oxygen species (ROS) and cationic antimicrobial host 
defense peptides (HDPs) to kill foreign cells. These antimicrobial peptides can kill bacterial cells 
through a variety of mechanisms, attacking the cell membrane and/or intracellular targets (37-39). 
More than 2700 of these peptides has been discovered in different families but, this research is 
focused on the specific family called piscidins (18). Piscidins are derived from fish (hybrid striped 
bass) mast cells and play very significant role in antimicrobial defense in the fish innate immune 
system and are occasionally part of adaptive immune responses as well (25), piscidin-1 (p1) and 
piscidin-3 (p3) are the two antimicrobial peptides which play important role in this study.  
These two peptides are intrinsically disordered in solution and contain a high number of 
hydrophobic amino acids (26). They differ in their antimicrobial mechanisms with p1 targeting the 
bacterial membrane and p3 showing a strong intracellular nuclease activity (26 & 27).  
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The piscidins each contain 22 amino acids residues, of which about 60% are hydrophobic 
in nature, and conserved amino terminal regions. Figure 2 showed conserved region and conserved 




This conserved region can bind some transition metals (like copper(II) and nickel(II)) and 
is called the amino terminal copper and nickel binding (ATCUN). The ATCUN regions for p1 and 
p3 are FHH and FIH amino acid residues respectively. The two piscidins fold into alpha helical 
secondary structure but are inherently stable (28). The piscidin-3 peptide structure is shown in the 








Figure 3:  PDB CODE: 2MCX. The α-Helix structure of piscidin-3 found by solid-
state NMR. Figure adapted from pymol protein structure software. 
 
Figure 2: The amino acid residues conserved in p1 & p3. The three underlined 
N-terminal amino acid residues represent the ATCUN region for binding of Cu2+  
and Ni2+ respectively.   
2MCX:A|PDBID|CHAIN|SEQUENCE      FIHHIFRGIVHAGRSIGRFLTGX 
2OJM:A|PDBID|CHAIN|SEQUENCE      FFHHIFRGIVHVGKTIHRLVTG- 




The transition metals copper has well-known antimicrobial metallic properties. It has 
bactericidal effect in its ground state (Cu) and in multiple ionic state, most commonly Cu(I) and 
Cu(II) (29 & 30). The capability of this transition metal to act as an antimicrobial agent alone or 
coordinate to other ligands to form different complexes are exploited by many scientific studies 
(29). Recently, Cu and its complexes are used in water purification and hospital waste 
management.  
Today, much scientific research support copper been algaecide, fungicide, nematicide, 
antimicrobial and antifouling agent respectively (29 & 31).  
In the +2 oxidation states (Cu(II) [Ar] 4s0 3d9), copper can coordinate up to six bonds 
resulting into an octahedral shape, which is very useful in the formation of many complexes. The 
p1 and p3 ATCUN motifs have been shown to bind Cu2+ in a 1:1 stoichiometric measurement with 
Nano molar affinity (31). At the ATCUN amino acid residues, Cu2+ binds directly to the two 
subsequent backbone amide nitrogen and the terminal nitrogen on the conserved histidine of the 
peptides (32). These two disordered peptides show high antimicrobial activity against a variety of 
pathogenic bacteria (31).  
Both peptides inhibit bacterial growth, kill actively growing bacterial, and can disperse 
bacterial biofilm (28). The efficacy of both peptides is enhanced by Cu2+ binding (31 & 43). The 
production of reactive oxygen species (ROS) in the presence of these peptides when planktonic 
bacteria are exposed to them create an imbalance between ROS and the bacterial defense, leading 
to high oxidative stress experienced, either at the membrane (leading to membrane disruption) or 
covalent DNA damage (nuclease activity) (40, 41 & 42). The peptides performance in an anaerobic 
environment have yet to be tested, but HDPs have shown to have antimicrobial activities in all 
parties of the body tissues including anaerobic ones.  
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So, this work examines the effect of HDPs (piscidins and their complexes) on Clostridium 
difficile in an anaerobic environment. Piscidin activity is assessed against C. difficile, an obligate 
anaerobic bacterium, and Escherichia coli and Pseudomonas aeruginosa facultative anaerobes 
capable of living in aerobic and anaerobic environments. The methods applied for combating these 
bacteria started from the measurement of minimal inhibitory concentration (MIC), the peptide 
concentration required to inhibit the bacterial growth called minimal inhibitory concentration 
(MIC) peptide concentration required to inhibit the bacterial growth (44). Time kill assays, 
determined the rate of peptides killing of C. difficile vegetative cells and the amount of biofilm 
formed in the presence of peptides, their copper complexes and transition metals alone are 
measured (31). The method helps to elucidate the antibiofilm properties of piscidins on C. difficile 















2.1 INNATE IMMUNE SYSTEM AND OXIDATIVE STRESS 
The innate immune system, also known as the first line of immunological defense in 
advanced organisms, is fast and has having multiple mechanisms to attack pathogens. This protects 
host organisms (higher animals) from foreign pathogens, before the more comprehensive adaptive 
immune system is activated (51). Infection recognition is a complex process initiated by the 
pathogen’s production of specific molecules called pathogen-associated molecular patterns 
(PAMPs) which are sensed by host pathogen recognition receptors (PPRs). This triggers the innate 
immune system to release a series of anti-pathogens substances like host defense peptides (HDPs), 
cytokines, chemokines and sometimes type1 interferons (52). Some of the innate immune system 
molecules generate reactive oxygen species (ROS) and /or reactive nitrogen species (RNS) to help 
combat the harmful microbial cells (54). 
Oxidative stress is the disturbance in the balance between the production of reactive oxygen 
species (ROS) and antioxidant defenses in organisms’ system. Oxidative stress is known to be “the 
imbalance that exist between oxidation and antioxidation in a system, in which oxidation exceed 
the counter effect of the system” (46). Oxidative stress in the system is a very detrimental process 
because it results in the damage including DNA mutation, lipid peroxidation, and oxidation of 
membrane layers. It is also employed by the body’s innate immune system sometimes to combat 
foreign bodies (46). Oxidative stress is well documented in many organisms. It can occur in 
different parts of many systems and they are implicated in many heavy metal ions’ toxicities 




2.2 METAL ION INDUCED OXIDATIVE STRESS   
 Transition metals can induce oxidative stress due to the ability to change their oxidation 
states (50).   Gallego et al conducted a study which involved the treatment of plant leaves with 
0.5m of Fe(II), Cu(II) or Cd(II) ions. Their study showed that after incubation, chlorophyll and 
glutathione (GSH), activity decreased but peroxidation and lipoxygenase activity increased. This 
result concluded that excess ions of these metals created oxidative stress for the plant leaves’ cells 
(47).  
Copper(II), or cupric ion, is the form of copper most likely to induce oxidative stress via 
its reduction to Cu(I) (cuprous ion) in a biological system, when in the presence of a strong 
reductant. Scheme 1 shows that this process results in the decomposition of hydrogen peroxide 
through the Fenton reaction process. Cupric ion does not cause oxidative stress directly. Instead, 
the (free radicals and reactive hydroxide ions generated in these reactions, cause the oxidative 
damage to biological molecules) (48). 
More evidence demonstrated how metallic-induced oxidative stress through a 
multifunctional mechanistic process decomposed hydrogen peroxide (49). The result of that study 
also identified an indirect mechanism, sulfhydryl reserves which was hypothesized to be by redox-
inactive metals (50). Many transition metals induce their form of oxidative stress because they can 
easily change their oxidation states (50).  
 
Scheme 1: Cu(II) production of both free radical and ionic hydroxide in the presence 





2.3 HOST-DEFENSE PEPTIDES (HDPs) INDUCED OXIDATIVE STRESS  
The elevation of reactive oxygen species (ROS) in the host cell’s physiology can either aid 
pathological processes by bacteria or kill the bacteria by host deference systems (53). Many host-
defense peptides combat bacteria by introducing oxidative stress on bacterial cell surfaces or in 
the bacterial cytoplasm (54). The innate immune systems produce these host-defense peptides to 
act as broad-spectrum antimicrobial agents in the body (18 & 31).   
HDPs in the innate immune system have immunomodulatory activities, apart from acting 
directly as antimicrobial peptides (18). That is, they can also recruit leukocytes to the site of 
infection, suppress the potentially harmful inflammatory responses, stimulate angiogenesis and 
wound healing (55), because of all these functions include upregulation of chemokines (a group 
very small proteins that attract T-cells to site of injury) production. HDPs are ubiquitous in all 
complex organisms’ innate and sometime adaptive immune system. As such they are strong 
candidate for new antimicrobial drugs. Figure 4 shows how these peptides can directly attack the 
membranes of bacteria (like membrane targeting piscidin p1) or target the intracellular DNA of 






2.4 PISCIDINS AND THEIR METAL COMPLEXES 
Piscidin are a prominent family of HDPs first discovered in the mast cells of vertebrates 
(31). These broad-spectrum antimicrobial peptides were isolated in hybrid bass striped fish 
(Morone saxatilis) and NMR studies suggest that they are intrinsically disordered in solution but 
adopt an amphipathic α-helix structural conformation when bound to model membranes (31 & 58). 
Piscidins can be isolated from other fish species and their ubiquity can be justified in fish because, 
fish are constantly exposed to pathogens (59 & 60). 
The piscidin focused on in this investigation are p1 and p3 respectively. They are 
bactericidal in nature, but their mechanisms of action are different (31).  
Figure 4: The illustration of biological roles of HDPs by innate immune modulation, 
peptides direct killings and intracellular target killings. Adapted from Robert E. W. Hancock & 




These two peptides (p1: FFHHIFRGIVHVGKTIHRLVTG and p3: 
FIHHIFRGIVHAGRSIGRFLTG), are intrinsically disordered in solution. This is likely due to 
the high numbers of hydrophobic amino acid residues in these peptides, compared to the 
hydrophilic residues. p1 & p3 are isoforms of one another with similarities and variations in their 
biological activities, specifically varying where they attack bacteria (i.e., p1 attacks the cell 
membrane and p3 the DNA) (26-31).  
The overall positive charge in the piscidin peptides’ amino acid residues helps them to 
interact with the phospholipids of the cell membrane and/or the acidic backbone of DNA, causing 
reactive oxygen production that leads to oxidative stress within the cell bilayer membrane (26). 
Piscidins also employ the same method in the intracellular targets, and they can be self-promoting, 
inserting themselves into the bilayer cell membrane and interrupting the membrane integrity (55). 
2.5 OXIDATIVE STRESS RESPONSE IN BACTERIA  
Bacteria use different methods to respond to oxidative stressors encountered in their 
environment from various sources like drugs, metals, nutrients, host defense system and sometimes 
UV-radiation (62 &63). The nutrient in their surroundings are both helpful and harmful, 
particularly those that create imbalance in their oxidative environment (62). In some cases, the 
oxidative stress experienced by bacteria are because of ROS, and RNS (63). Some well-known 
oxidative stress responses in bacteria during anomalous growth process are of two main types’ 
gene regulation and/or repair responses (62). 
The oxidative stress gene regulation response is the production or increased activity rate of 
antioxidant enzymes or proteins (like the OxyR system for hydrogen peroxides and the SoxRS 
system for superoxide) in bacteria (65). The OxyR and SoxRS system for regulation of oxidative 
stress created by ROS and others are said to be conserved in both Gram-positive and Gram-
negative bacteria (66).  
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The repair response is focused primarily on DNA either by exertion or methylation repair 
methods of the bacteria genes (64). Some bacteria have other response to oxidative stress or 
extracellular stress in general, including the production of biofilm. 
2.6 BIOFILM AS STRESS RESPONSE  
Biofilms are structured multicellular communities of microorganisms that adhere to 
surfaces (67). Bacteria biofilm are associated with more than 65% of infections and recurrent 
infections in hospitalized patient in the United States of America alone and lead to high rate of 
chronic diseases in humans’ health around the globe (67 &68). Biofilm containing multiple or 
single bacteria taxa, are mostly composed of a secreted exopolysaccharide matrix which protect 
the cells within the biofilm from extracellular stress, including antibiotics (76) Cells in a biofilm 
can be up to 1000-fold more resistant to antibiotics than cells of the same bacterial species outside 
of a biofilm (69). Growth in a biofilm also leads to changes in bacterial metabolism and gene 
expression (66). 
Hundreds of genes are responsible for stress associated biofilm formation in bacteria. One 
example is the MqsA/MqsR pair of genes in E. coli that induce biofilm formation in response to 
toxin stress has antitoxin stress (70). Biofilm production has been reported as a direct response to 
antibiotic stress (71). In May 2014, Cesar and colleagues implicated biofilm formation as part of 
stress response to antimicrobial peptides (68). 
2.7 OXIDATIVE STRESS RESPONSE IN BACTERIA  
The oxidative stress experienced in both aerobic and anaerobic bacteria differ because of 
the availability of oxygen. While aerobes make use of oxygen to produce energy, ROS are also 
produced as by-products that can be harmful to their cells (72). Anaerobes also experience 
oxidative stress. Since this stress is not only external or extracellular based only, ROS can also be 
generated intracellularly (62). 
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2.8 OXIDATIVE STRESS RESPONSE IN AEROBIC BACTERIA  
Aerobic bacteria that use oxygen in respiration can also create “ROS” and RNS, which 
leads to oxidative stress (62). The response of bacteria to this type of stress is the production of 
antioxidant enzymes (62). The innate immune system also adopts this strategy against foreign 
bodies through the production of different molecules or peptides that initiate or induce a process 
called the “oxidative burst” (51-54 & 62). Some of the antioxidant enzymes used by the bacteria 
are superoxide dismutase (SOD), catalase, alkylhydroperoxidaes, superoxide reductase and 
peroxidase. The co-factor for most of those antioxidant enzymes is iron. Iron can absorb the 
electrons that make ROS reactive, but excess iron can also result in metallic ion oxidative stress 
for the bacteria (62). 
Pseudomonas aeruginosa and Escherichia coli are facultative anaerobes that can live in 
the presence of absence of oxygen. Pseudomonas aeruginosa is a Gram-negative bacterium that 
can be a life-threatening with strong resistance to antibiotics (8). The model P. aeruginosa strain, 
PA01, was isolated from a wound, while other strains were found in from burns and cystic fibrosis 
(9 & 10). 
P. aeruginosa, is an opportunistic, infectious bacterium that causes chronic infection in 
patients who already have cystic fibrosis, increasing their mortality rates (12 & 13). This 
opportunistic pathogen, well-known for its large biofilm formation also causes chronic biofilm 
infection and has ability to form three exopolysaccharides types of biofilm (14 &15). The high rate 
of infection by P. aeruginosa, has been traced back to the bacteria ability to grow and flourish 
easily in sputum, found in large volume along the human airways. So, in the case of cystic fibrosis 
of the lungs (CF Lungs) they can be easily determined in the sputum after 50 minutes of infection 
(16 & 17). Unlike E. coli, Pseudomonas aeruginosa (PA01) makes use of many genes and complex 
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way of responding to oxidative stress, including formation of large amounts of biofilm. P. 
aeruginosa PA01 exhibits high rates of biofilm formation and copper-piscidin complexes have 
been previously demonstrated to disperse PA01 biofilms (31).  
PA01 genes that combat oxidative stress are katB-ankB, ahpB and ahpC-ahpF (73). In-
vitro the katB-lacZ reporter expression level increased 250-folds when cells were exposed to 
oxidative generating compounds (H2O2-generating compounds) (73). Both anhB-lacZ and ahp-
lacZ expression level increased by 90 and 3 folds respectively when the bacteria are induced by 
paraquat (an oxidative generating compound), within 5 minutes (73).  
The mutant PA01 (∆oxyR) does not express those genes mentioned before when exposed 
to either of the oxidative generating compounds above and any other form of oxidative stress 
because exposure to the same compounds kill the mutant  before gene expression can change.  
They are highly susceptible to oxidative stress but, none of the oxidative stress genes get expressed. 
What was inferred from this was that oxyR is responsible for the control of oxidative stress 
response genes and those genes are used to counter the effect of oxidative stress in P. aeruginosa 
(62, 70 – 73). 
Escherichia coli is a known Gram-negative bacterium and widely spread in food, water 
and air contamination (19). E. coli can live aerobically or anaerobically and responds to oxidative 
stress by two well documented strategies of antioxidant enzyme formation and DNA-repair protein 
formation, as well as biofilm formation as a result of oxidative stress (68, 70 & 71). 
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2.9 OBLIGATE ANAEROBE 
Clostridium difficile is the only obligate anaerobic microbe principally investigated in this 
research.  
This bacterium is a flagellated, Gram-positive rod-like (bacillus), and has two states in its 
life cycle (1). Dormant non-metabolizing spore are resistant to oxygen, alcohol, and other stresses. 
Spores let the bacteria spread through the oxygenated environment to new hosts (34). The actively 
germinating phase that can produce spores and cause infection through the production of exotoxin 
Figure 5: The life cycle of Clostridium difficile. Adapted from Karissa Culbreath et al. Journal of 
clinical microbiology, Oct. 2010, p. 3738–3741 
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in C. difficile life cycle the vegetative cells (3 & 75). This destructive phase is the main target of 
this investigation. The vegetative cells highly antibiotic resistant, and they form biofilm. Their 
biofilm in the hypervirulent strains aid in the bacteria protection and infection processes (1-7 &33). 
All the life cycle stages are described in Figure 5 (1, 2 & 75).   
2.10 C. DIFFICILE VEGETATIVE CELLS AND PATHOGENESIS 
C. difficile is the causative agent of hospital related antibiotic-associated diarrhea and 
pseudomembranous colitis (1 & 2). The bacteria produce two main toxins in the intestine called 
toxin A (Ted A) and toxin B (Ted B), some strains of C. difficile also produce a third type of toxin 
called binary toxin (CDT) (74).  
The pathogenesis of this bacterium starts from the vegetative cell production of toxin after 
colonization of the animal gut (33). When the innate immune response of the host cells fails, 
bacteria colonization increases, and disease symptoms set in, shown in the figure 6 flow chart. 
Unless the antitoxin treatment works, or vegetative cells are killed off before toxin production, the 
symptoms rapidly surface in the infected individual (75). The major risk factor which increases 
susceptibility to CDI is the disruption of microbiota intestinal community is antibiotics and others 






Figure 6: Pathogenesis of Clostridium difficile Infection. Chart adapted from Daniel A. 
Leffler and J. Thomas Lamont N Engl J Med 2015;372: 1539-48  
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2.11 C. DIFFICILE AND ANTIMICROBIAL AGENTS 
Treatment with fluoroquinolone antibiotics results in the disruption of microbiota 
communities that normally out-compete C. difficile for nutrients and allows C. difficile 
colonization and CDI associated diarrhea with roughly 33% recurrence after treatment (34). The 
antibiotic was meant to fight microorganisms but in doing so, it created an environment susceptible 
to the C. difficile infection, Jacques Pepin et al have found similar results with the antibiotic 
metronidazole used to treat recurrent CDI; 33.3% of patients had a second recurrence after 
metronidazole treatment (34). Both studies not only point out that antibiotics have not been 
effective against C. difficile, but also indicate promotion of adaptive C. difficile strains in the toxins 
production by this pathogen [5 &34]. According to the medical community of the early 1980s the 
use of metronidazole and vancomycin were effective antibiotics against C. difficile, but in recent 
years, the high rate of recurrence, despite the usage of those antibiotics, is not just anomaly it is a 
serious and an ongoing problem (34 & 35).      
The Center for Disease Control and Prevention (CDC) warned against the usage of those 
two antibiotics in treatment of Clostridium difficile-associated disease (CDAD) to avoid 
vancomycin resistant enterococci and staphylococci bacterial infections. This reduced the 
confidence level in these antibiotics and set stage for a new and urgent need for antimicrobial drugs 
[35].  Another study by Hetch D W. and Galang M. A et al, used 15 well-known antibiotics against, 
110 toxigenic clinical strains of C. difficile to check effectiveness. This study came about as a 
result of the decrease in confidence in the use of antibiotics against this bacterium. Yet, none of 
the 15 antibiotics were able to kill the strains of Clostridium difficile in-vitro. Table 1 shows the 




In view of this looming antimicrobial failure, we turn to naturally occurring antimicrobial 
peptides, HDPs. These peptides, as already discussed, channel oxidative stress that they create 
against bacteria cells to kill them (30 &31). The peptides alone, their complexes and sometime 
copper alone can generate diverse oxidative stress, which can quickly overwhelm the bacteria cells, 
resistance will not easily be develop against them. Moreover, it is possible that as the piscidin are 
naturally produced in organisms’ immune systems, health challenges posed by them may be low.  
2. 12 OXIDATIVE STRESS RESPONSE IN C. DIFFICILE 
C. difficile an anaerobic bacterium but, can survive oxygen level up to around 2%. So, C. 
difficile must have mechanisms of defense to tolerate oxygen molecule and ROS generated as a 
result of responding to oxidative stress from these oxygen molecules as well as antimicrobial 
Table 1: Distribution of antimicrobials tested against 110 toxigenic clinical C. difficile isolates 
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peptide peptides and metal ions (77).  Aside the endogenous ROS that might be produced during 
metabolic reactions of the bacteria. Antimicrobial peptides, metal ions and oxygen molecules can 
aggravate the situation (49 & 56).  
In C. difficile the oxidative stress response has yet to be well established, although ROS 
scavenging enzymes like catalase, peroxidase and superoxide dismutase (SOD) have been 
identified being identify on their spores.  The vegetative cells’ defense against oxidative stress 
require more intensive investigation because reports on this aspect of bacterial physiology are not 
yet sufficient.  A conserved putative superoxide reductase (SOR) is also encoded in the C. difficile 
genome and expressed in transcriptomic and proteomic studies of vegetative cells (80).   The 
sensitive of C. difficile to piscidin peptides and complexes with the oxidative stress response of 
this bacterium to metal ions are reported in these investigations.   
 
















CHAPTER 3                                           
RESEACH OBJECTIVES 
The advent of failure in many strong antibiotics against the Clostridium difficile and the 
fast adaptation of the bacteria to them, there is urgent need for antimicrobial agents that can kill 
and minimize the adaptation of the bacteria to them. Oxidative stress adaptation in bacteria are 
difficult because it can come from diverse sources, like transition metal ions and antimicrobial 
peptides produced by animal immune systems. The objective of this research is to: 
1. Characterize the oxidative stress response of C. difficile to antimicrobial peptides and 
transition metals  

















4.1 MATERIAL AND SAMPLES 
LB-broth, Agar, Bacto yeast extract, BHI (Brain-Heart Infusion), Glucose, drugs are Host 
defense peptides (HDPs) piscidin-1 (p1), piscidin-3 (p3), CuSO4, CuCl2 and Cu(NO3)2 (Cu2+) and 
piscidin complexes. Piscidins and complexes were provided by the Cotton lab (William and Mary). 
Na2PO4, Nuclease free water, TY-media, dry ice, 630 ∆erm Clostridium difficile strain (lab strain), 
R20291 Clostridium difficile strain (virulent strain), Escherichia coli (DH5 alpha Lab strain from 
New England Biolabs, PDJ1 and MWF1 two gift strains from Liberdo lab) and Pseudomonas 
aeruginosa (PA01 strain). 1×PBS, 1% crystal violet, variable percentage of Ethanol Antibiotics 
(Ampicillin and Kanamycin). Unless otherwise specified, reagents were purchased from Fisher 
scientific. 
4.2 INSTRUMENTATIONS 
Centrifuge (1) Accuspin micro 17 (Fisher Scientific) (2) Legend micro 21R 
(Thermoscientific), Imaging is through syngene image (U); Genius 3. Optical density (OD); (1) 
Genesys ws UV-Vis spectrophotometer (Thermoscientific) (2) Smart Bio drop (Dr. Pascal’s lab) 
(3) Ultraspec 10 (Bio-Rad), Anaerobic chamber (Coy laboratories), Incubator and sample shaker 
Max Q 6000 by (Thermoscientific), Dry and wet bath (Thermoscientific and Corning/LSE). 







4.3 MINIMAL INHIBITORY CONCENTRATIONS (MIC) 
4.4 MIC FOR P1 AND P3  
The minimal inhibitory concentrations MIC for p1 and p3 was verified for both ∆erm 630 
strain and virulent strain of R20291 respectively. Four biologicals of both C. difficile. Strains were 
cultured in TY-media for 24hrs at 370C in the anaerobic chamber’s incubator using glass test tubes. 
After 24hrs these cultures were used to inoculate fresh culture in 96 well plates, leaving the first 
and last columns in the plate full of non-inoculated medium as blanks. Each experimental well 
contained peptide and /or copper at the indicated concentration and the total volume /well was 
constant at 200µl, with volume adjusted as needed with nuclease free water. Inoculated plates were 
incubated at 370C for 16 hours. 
After 16 hours plates were taken out of the chamber, plate exteriors were sterilized with 
bleach, and plates were read at 630/nm excitation wavelength in Bio-Tek plate reader. The 96 well 
plates used for these experiments has been deoxygenated in the anaerobic chamber for more than 
72hours before usage. 
4.5 MIC FOR Cu2+ CONCENTRATIONS 
Four fresh cultures of the two C. difficile. Strains (R20291 and 630∆erm) were inoculated 
from overnight in 96 well plates with TY medium containing copper ion in a gradient concentration 
from 64uM to 0.5uM incubated and measured as described above.  We employed three different 
strains of E, coli (DH5α, PDJ1, and MWF1 respectively) to establish the piscidin MICs for them 
in the presence and absent of oxygen. Anaerobic cultures were grown in the incubator in the 
anaerobic chamber and aerobic cultures were grown in a laboratory incubator. We maintained the 
same MICs growth assay steps and setup already discussed above and after 16 hours growth data 
was obtained with the plate reader. 
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4.6 BIOFILM ASSAY  
4.7 P1 AND P3 BIOFILM ASSAY  
 We grew four biologically independent cultures of R20291 and inoculated 2 mL/well of 
BHIS media supplemented in 1% glucose and 50 mM Na2PO3 pH 7.4 with 20µL of saturated 
culture in 24 well plates. Culture were incubated for 2 hours before treatment and left in incubator 
at 370C for 24 hours. Plates were degassed in the anaerobic chamber for 72 hours before using. 
Biofilm cultures contained piscidin and/or copper at the indicated concentrations. After 24 hours 
of growth, cell density measured at 630 nm. Afterwards, non-adhered cells were removed so 
biofilm could be measured. 
Carefully slant the 24 well plates to remove the media without allowing the pipette tips to 
touch the bottom part of the wells. Wash the left over in each well with 1×PBS, 1ml for each well, 
pouring the wash buffer gently and in slant orientation. Stain each well with 0.1% crystal violet 
and allowed to stand for 30 minutes or more. To the resulting setup after 30 minutes wash twice 
with 1×PBS 1ml each time again carefully. Then, suspend the left over in 70% ethanol and take 
the picture. Scan the plate with 570/nm wavelength, using the plate reader.  
4.8 PISCIDINS AND THEIR COMPLEXES BIOFILM ASSAY 
Well reduced 24 well plates, each well was filled with 2ml BHIS (glucose 1% and NaPO4 
p H= 7.4). Except for the first row, inoculate with 20ul of starter culture of R20391 of biological 
A, B, C, D, E & F respectively. No drug to the first column, 4uM of Cu2+ added to the second 
column only, third column contain 2uM of P1 only while fourth contain mixture of 2uM p1 and 
2uM Cu2+ fifth column was p3 alone and sixth well column contain the mixture of 4uM of Cu2+ 
and p3 each. The experimental setup was kept in incubator at 37OC in anaerobic environment for 
24hrs. After 24hrs, washing procedure, discussed earlier for other biofilm and piscidin 1 and 3 was 
carefully followed and plate reader used to scan the 24 well plate at 570/nm wavelength. 
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4.9 Cu2+ BIOFILM ASSAY  
P. aeruginosa and E. coli strains biofilm were grown in LB medium containing the 
indicated concentrations of copper ions rather than supplemented BHIS. The protocols for biofilm 
inoculation, growth, staining, and measuring were the same as those listed above. Duplicate plates 
were set up for P. aeruginosa and E. coli strains. To account for slower growth in anaerobic 
conditions, one plate was allowed to grow for 48 hours at 370C in the anaerobic chamber and one 
was allowed to grow 24 hours at 370C aerobically. 
4.10 TIME KILL ASSAY 
Four biologically independent cultures of R20291 were grown overnight in TY medium 
and then used to use to inoculate fresh TY medium. Culture were grown to mid-exponential phase. 
The culture density was measured by monitoring optical density at 600 nm (OD600). At OD600 
of 0.5-0.7, piscidin and/or copper were added at the indicated concentrations. At the indicated time 
points, 20 µL aliquots of treated culture were added removed and serially diluted 10-folds in fresh 
TY medium. Each sample was plated on BHIS plates at a 1:106 dilution and incubated 














                                     RESULTS AND DISCUSSIONS 
5.1 MINIMAL INHIBITORY CONCENTRATIONS (MIC) 
The following are the various results obtain for MIC of 630∆erm and R20291. 
5.2 MIC FOR 630∆erm AND R20291  
The minimum inhibitory concentration (MIC) is the lowest concentration sufficient to stop 
the growths of microbes’ in-vitro.  This is determined by inoculating media containing a 
concentration gradient of p1 and p3 peptides (from 0.063uM to 64uM) in a 96-well plate, with 20 
µL of saturated starter culture of R20291 and 630∆erm C. difficile to a final volume of 200µL per 
well. Uninoculated TY-medium was used as a blank. After 24 hours incubation, the plate reader, 
using 630nm wavelength, measured the cell density in each well. Figure 7 showed the growth 
curve for the two strains on three separate days. For the p1 the MIC was estimated on the curve to 
be 4uM, although growth decline started at 2uM. The MIC for p3 was 8uM and growth decline 
started at 4uM. The MIC determination for the two strains were carried out in the absence of 









Figure 7: The MICs for p1 & p3 against both strains of C. difficile 630∆erm & R20291 through 
measure of cell density after 24 hours. The figure above represents average three days data 
acquisition plots  
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5.3 MIC FOR R20291 USING DIFFERENT COPPER SALTS  
It has previously been reported that piscidin peptides have stronger antibiotic activity when 
complexed to copper ions (31). To investigate the effect of copper ions alone on C. difficile growth, 
three different copper salts were tested against the virulent R20291 C. difficile strain. The 
concentrations of the three copper salts employed ranges from 0 to 8uM. This is to test how those 
copper concentrations affect the growth of C. difficile virulent strain. Figure 8 below, as at 8uM, 
toxicity of copper(II) salts, no significant growth inhibitory effect and the bacteria growth was 






Figure 8: The copper concentration gradient for three copper(II) salts inhibitory effect 
against the virulent strain of C. difficile. 
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5.4 TIME KILL ASSAY  
5.4.1 Time kill assay for p1, p3 and their copper complexes 
The time kill assay was used to determine the killing rate of the peptides and their 
complexes in both presence and absence of oxygen. Unlike MIC assays, time kill assays measure 
the effects the peptides have on the C. difficile culture after they have been removed from the 
bacterial cells by dilution. The time kill made use of sub-MIC concentrations of p1 and p3. The 
concentrations used for p1 was 2µM and p3 was 4µM. To investigate potential synergy between 
piscidins and copper, piscidins were tested in the presence and absence of equimolar CuSO4. The 
method involved enumeration of colony forming unite per mL of culture (CFU/mL) of the treated 
and non-treated cultures after plating for 24 hours at 370C in the incubator.  
  Enumeration of colonies revealed p1 alone had not significantly reduced CFU/mL at t=0 
but the p1-Cu complex immediately reduced CFU mL by approximately 40% (Figure 9) in 
comparison to NT. After 30 minutes, there was significant killing in comparison to untreated CFU. 
Specifically, p1 vs p1+Cu only had low significant different at t=0 (p=0.0063) (Table 2) but as 
time progressed no other time point showed any significant difference between the peptide alone 
and its complex. The p3 and p3+Cu had no immediate impact after treatment because there was 
less than 5% difference between NT, p3 and p3+Cu and the comparison showed no significant 
difference at t=0 (Figure 10) (Table 3). Subsequently there were significant differences between 
the p3 and p3+Cu to NT at all other time points. More than 50% reduction in CFU had occur in 30 
minutes between the p3, p3+Cu to NT but, the peptide and its complex showed no significant 
difference in them. At the four-hour point, no significant difference occurred between the p3 and 
p3+Cu.   
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The data analyses (Table 2) showed there was initially no significant difference between 
the samples treated with piscidin-1 (p1) and untreated (NT) samples. The samples treated with 
p3+Cu complex had significantly lower CFU counts than the untreated samples (p < 0.001) and 
samples treated with piscidin alone (p < 0.001) at the zero time point. After 30 minutes of 
treatment, both p1 and p1+Cu were significantly different from the untreated samples (p < 0.001) 
but showed no significant different from each other, meaning copper initially accelerated p1 killing 
of the bacterial cells, but, the peptide alone quickly ‘caught up’ to the peptide-copper complex. 




Figure 9: The time kill curve for p1 and its copper complex lab mixture. The time kill 
assay data which resulted into the above Figure 9 was an average of the peptides 





 Figure 10: The time kill curve for p3 and its copper complex for lab mixture 






Table 3 above showed that at zeroth hour there was no significant difference in the three 
conditions NT, p3 and p3 complex. As time progress the trends noticed in p1 and its complex 
activities was the same at rest time points from half an hour to the fourth hour time point.  
What was noticeable during data analysis, neither p1 nor p3 showed significant changes to 
the killing rate when copper was added. This shows that adding copper in +2 oxidation states do 
not increase the peptides’ activities “rate of vegetative cells killing”.  This is directly contrary to 
what was previously measured against E. coli in aerobic conditions (31). The time kill assay was 
carried out several times over the course of four months. 
Table 3:  The p3 and p3+Cu time kill data analysis by two ways ANOVA 
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The copper concentration in the TY medium is 1.24 µM (Figure 14). This is low compared 
to the amount of copper added in the assays. To account for the possibility that the extra copper 
was being chelated by something else in the media and not forming complexes with piscidins, we 
repeated the assays using pre-formed piscidin-copper complexes. Figure 11 and 12 show the 
activities of the pre-formed peptides-copper’-complexes. In peptide p1+Cu and p1Cu complexes. 
Where, p1+Cu represent the lab mixture and p1Cu is for pre-copper complex, respectively. For 
any form of p1-copper complexes data analyses showed no significant difference in their rate of 
killing (Figure 11). The p3 and its two different copper complexes showed significant difference 
at starting point of t=0. This is likely due to slow chelation process between the peptide and copper 
compound, in this case CuSO4. As time progressed, particularly at the 4-hour time point, there was 
no significant difference in the killing rate of the two forms of peptide complexes. Figure 12 




       
Figure 11: Comparative data curve for p1+Cu and p1Cu complexes. Where p1+Cu and p1Cu 
represent the peptide copper mixed in the lab and pre-formed peptide-copper complexes. 









Figure 12: Comparative data plot for p3+Cu & p3Cu complexes. P3+Cu 






The time kill assay extended to the “sub-MICs” of p1 and p3 of copper(II) salts of 2uM 
and 4uM respectively, in copper(II) alone samples treatment. At t=0 to t=4, time point as 
previously done for the peptides and their complexes. The data curve (Figure 13) simply showed 
that at those copper concentrations, there were no significant killing of the R20291 C. difficile 
vegetative cells. The curve resulted from CFU/mL enumeration after 24 hours on each of the 
plates. The curve showed that copper(II) at 2uM and 4uM had an initial impact, but, the vegetative 
cells were able to recover as time went on. 











Figure 13: The time kill curve Cu2+ at 2uM & 4uM. This help to monitor 
what happed to C. difficile vegetative cells’ growth at each time point 
because of the copper concentration they are exposed to  
Figure 14: Copper concentration/µM curve as determined by FAAS in three 
different media. Concentration of Cu TY-medium is 1.24/µM, BHIS is 1.38/µM and 




5.5 BIOFILM INHIBITORY ASSAY 
5.5.1 BIOFILM ASSAY FOR PEPTIDES, COMPLEXES AND COPPER(II) 
We measured the effect of piscidin peptides in the presence and absence of copper on C. 
difficile biofilm formation. Biofilm were grown anaerobically at 37o C for 24 hours and then 
quantitated by crystal violet staining. Figure 15 showed the amount of biofilm formation in the 
treated and untreated 24-well plates, to a final volume of 2mL in each well. In contrast to previous 
reports that piscidins disperse biofilm formation in anaerobic conditions, and that copper enhances 
this effect, our results showed. Stimulatory effect in the treated wells, compared to the untreated 
control. Figure 12 shows the highest biofilm formation in Cu2+ treated wells, to be higher than the 
rest. This appear to be due to the copper, as the peptides did not further increase biofilm formation.  
Table 6 showed that the amount of untreated (NT) biofilm formed had no significant 
difference to the two peptides alone. More biofilm formation in the p1+Cu complex treated wells 
resulted into significant difference (p < 0.001) when compared to the NT and p3+Cu were not 
significant. However, any data comparison to copper(II) salt (CuSO4) alone biofilm formation, 
showed significant difference (p < 0.001), consistently and convincingly. Other comparison not 
against CuSO4 treated ones are not affirmative, but, when compared with the copper salt alone its 
straight forward significant difference.  
This result prompted a lot of questions rather than answers. We continued to investigate 
the metallic oxidative stress response in C. difficile virulent strain (R20291) and high biofilm 
forming mutant strain (RT527). The comparison of p1+Cu to p3+Cu showed significant difference 
(p = 0.0059), this may be because of p1 and its complex having more of its bactericidal activities 






   
Figure 15: The amount of biofilm treated and the untreated control. Treated ones are 
peptides, peptide-copper complexes and copper(II) alone. NT in this figure represents 












Table 6: The data analyses of peptides and their complexes with copper salt alone  
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5.6 BIOFILM METALLIC STIMULATORY EFFECT 
 We measured the effect various copper(II) salts on biofilm formation in C. difficile R20291 
and RT527, or R20291 pDccA, a strain with elevated c-di-GMP levels and high biofilm formation 
(33). The C. difficile strains were exposed to gradient concentrations of copper(II) salts. These 
concentrations appear to stimulate more biofilm formation, in direct relation to increased 
concentration. The biofilm production almost showed linear proportionality (Figure 16 and 17) the 
curve of the two strains in the increase Copper(II) concentration.  
Table 7 and 8 respectively showed no statistically significant differences due to copper 
treatment. The figures however, showed trend towards increase biofilm formation response to 
increases in copper(II) salt concentrations when compared to untreated well. In RT527, known for 
its large biofilm formation capability, the copper(II) salt gradient concentration was from 0.25/µM 
to 2/µM. However, in further investigations the concentration level may be raised, but at these 
concentrations the figure showed the trend, but differences were not statistically significant. The 
trend did concur with that seen in the initial piscidin with or without copper experiments (Figure 
12). 
Investigations continued with the usage of other copper(II) salts, CuSO4, CuCl2 and 
Cu(NO3)2 respectively. The stimulatory effect appeared to be the same in R20291 and RT527. 
Figure 18 shows the different copper(II) salts curves. The figure showed a mild stimulatory effect, 
but, according to the data analyses (Table 9), there were no significant differences in the amount 
of biofilm formed. Notably, addition of any type of copper(II) salts do not inhibit biofilm formation 
in C. difficile rather it appears to stimulate more biofilm formation in all experimental results as 
seen in figure 18. So, the anaerobic compared to aerobic antimicrobial activities of copper and 





Figure 16: The copper salt (Cu2+) alone concentration gradient for biofilm 
































Figure 18: The different Cu2+ biofilm quantitative effect curve. Each bar from NT to 4uM 
















The characterization of the Clostridium difficile oxidative stress response and antimicrobial 
effect of piscidin peptides and complexes on these bacteria was determined in anaerobic 
conditions. The p1 has a lower MIC (4µM) than p3 (8µM) but both the piscidins are active 
antimicrobial peptides in anaerobic conditions against Clostridium difficile. Their antimicrobial 
activities include growth inhibition and permanent bacterial killing.  The killing rate in the absence 
of oxygen invitro gave these confirmatory results. In the time kill assay, p1 and its copper complex 
had started killing immediately after treatment while it takes 30 minutes for p3 and its copper 
complex to show any bactericidal activities. The estimation of number of colony forming unite 
(CFU) at each time points till the fourth hour, was that the total number of CFU in p1 and its 
complex compared to p3 and its complex. As a result of these data analyses p1 appear to be a 
slightly better antimicrobial agent than p3 in an anaerobic environment. This is consistent with 
what was previously observed aerobically but the lack of synergy between piscidins and copper is 
novel to this work. 
In the absence of piscidin, copper(II) alone at the sub-MICs of both peptides’ p1 and p3 
which were 2uM and 4uM sub-MICs respectively. At these concentrations there was no significant 
killing of the bacteria. Within half hour exposure of the bacteria, the metallic oxidative stress 
inferred from the CFU plot at this time point, showed lower number of viable cells. However, the 
bacteria cells were able to overcome the stress within two hours and the CFU showed they had 
recovered from the oxidative stress.  
The peptides in comparison to their complexes show no significant difference in their 
bacteria killing rates. So, the bactericidal activities of both peptides are not enhanced by the 
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presence of copper(II) ion as the time progressed in the anaerobic environment. This is a direct 
contrast to what was observed in Gram-positive and Gram-negative bacteria in aerobic 
environment by Daben J. Libardo et al in 2017.   
The lab mixed and pre-complex “piscidin complexes” had approximately the same end 
results in their killing rates, confirming that the peptides are not failing to form the complexes in 
those conditions tested. This result confirmed that the mixed copper(II) salts are not used up by 
any other C. difficile metabolic activities and they got to the targets in the media. This means that 
while the piscidin peptides and copper ions can both induce stress in C. difficile, the peptides and 
copper ions do not exhibit the same synergy in an anaerobic environment that they do aerobically. 
The biofilm prevention assay appears to have different result in anaerobic environment to 
the bacteria biofilm dispersal assay in aerobic environment as reported. It was previously report 
that modest inhibitory activities occur when peptides alone are used for biofilm inhibitory assay. 
The same assay in the presence of peptide complex, showed stronger biofilm clearance was 
reported in aerobic condition. In anaerobic conditions peptides and their complexes do not show 
any biofilm inhibitory effect, but, the peptide complexes and metal alone at sub-MICs tend to show 
stimulatory effect. So, C. difficile appears to respond to oxidative stress through formation of more 
biofilm to protect themselves from the reactive oxygen species generated in the oxidative stress 
process. The investigations up to this point support the conclusion that the peptides’ antimicrobial 
mechanisms and metallic ion interactions appear to be different based on their environment and 
their targets. So, drugs design based of these peptides, the designer must keep in mind the 
environment and the physiological target of the peptides. The aerobic and anaerobic biofilm 
formation in E. coli strains are really promising and this among others will be forming the bases 
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